Navigation Links
DePuy ASR™ MDL Lawsuit Update: Settlement Reached in the DePuy ASR™ Hip Implant Multidistrict Litigation (MDL 2197)
Date:11/28/2013

St. Louis, MO (PRWEB) November 28, 2013

According to court documents filed in the United States District Court for the Northern District of Ohio in the Multidistrict Litigation In re: DePuy Orthopaedics Inc., ASR™ Hip Implant Products Liability Litigation, MDL 2197 (Case No. 10-md-2197), the settlement agreement has now been released. The settlement agreement outlines that there will be a base payment of $250,000 for each plaintiff involved in the federal multidistrict litigation (MDL 2197) who has underwent revision surgery to remove the ASR™ hip implant by or before August 31, 2013. Additional monies could be offered for persons who underwent bilateral revision or re-revision surgeries. However, there are additional factors that must be taken into consideration for each particular case and would potentially reduce the amount of the plaintiff’s base payment of $250,000, including but not limited to the following factors: body weight, length of time that the device was implanted, smoking history, and age.

The deadline for plaintiffs to register to participate in the settlement is January 6, 2014 and all necessary enrollment documents must be submitted by April 1, 2014. The settlement agreement outlines that the manufacturers have the right to walk away from the settlement if more than 6% of those eligible to enter into the settlement do not enroll by the deadline. If there is sufficient participation in the settlement, then it will proceed with payments made under the settlement agreement in the summer of 2014.

Kristine Kraft, partner at Schlichter, Bogard & Denton, LLP representing victims of dangerous pharmaceutical medications and unsafe medical devices, stresses that it is very important for victims implanted with DePuy ASR™ devices to consult with an attorney. Kraft stated, “Any person implanted with DePuy ASR™ devices should speak to an attorney for careful consideration of their claim pertaining to the settlement in order to protect their rights, especially in a mass settlement such as this.”

Since the withdrawal of the DePuy ASR™ (Articular Surface Replacement) hip device from the market in August 2010, thousands of lawsuits have been filed against Johnson & Johnson in the federal Multidistrict Litigation pending in the Northern District of Ohio (MDL 2197) alleging injuries to persons who had the defective DePuy ASR™ hip products implanted during hip replacement surgeries. According to the most recent report from the Judicial Panel on Multidistrict Litigation, there are over 8,500 cases pending in the DePuy ASR™ Multidistrict Litigation (MDL 2197).

According to a recent report by The New York Times,93,000 patients have had a DePuy ASR™ hip device implanted. More importantly, Johnson & Johnson knew - even as far back as 2008 – that nearly 40 percent of patients with a DePuy ASR™ hip would experience total failure within five years. In a separate article published in January, The New York Times reports that the FDA has now issued new guidelines for the approval of metal-on-metal (“MoM”) implants, which include a provision that any MoM implant must first undergo rigorous, comprehensive clinical testing prior to being introduced to the market.

About Schlichter, Bogard & Denton, LLP
Schlichter, Bogard & Denton, LLP is a unique law firm that aggressively represents victims of dangerous pharmaceutical medications and unsafe medical devices. With hard work, creative thinking, and strong trial skills, we have earned an outstanding nationwide reputation by representing thousands of individuals who have suffered serious injuries or death as a result of dangerous pharmaceutical drugs and medical devices. If you or a loved one has experienced complications with a DePuy ASR™ hip device, please contact the experienced attorneys attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297 for your confidential and free consultation.

The choice of a lawyer is an important decision and should not be based solely on advertisements. The cases discussed do not predict outcomes in future cases. Past results afford no guarantee of future results and every case is different and must be judged on its own merits.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11377769.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Chicago Personal Injury Firm of Salvi, Schostok and Pritchard P.C. Calls Attention to Proposed $2.5 Billion DePuy Hip Implant Settlement
2. DePuy ASR Lawsuit Settlement Proposal Moves Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy ASR Recall Litigation
3. DePuy ASR Settlement News: Bernstein Liebhard LLP Notes Appointment of Special Masters, Claims Administrator to Oversee Proposed DePuy ASR Lawsuit Settlement
4. DePuy ASR Lawsuit Settlement News: Johnson & Johnson Deal Still Leaves Opportunity to File Lawsuits, Notes Rottenstein Law Group LLP
5. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes Scheduling of Remand Hearings for Federal Pinnacle Hip Lawsuits
6. DePuy ASR Lawsuit Settlement Excludes Many Individuals Who May Have Been Harmed by Devices Included in DePuy ASR Recall, Bernstein Liebhard LLP Reports
7. DrugRisk Adds Latest Court Update on DePuy Hip Lawsuits
8. DePuy ASR Lawsuit Settlement News: Bernstein Liebhard LLP Comments on Announcement of DePuy ASR Recall Settlement
9. $2.5 Billion Settlement In DePuy ASR Hip Replacement Lawsuits, Reports Wright & Schulte LLC
10. DePuy Settlement Update: Nov. 19 Conference Could Involve ASR Hip Settlement Talks, Rottenstein Law Group LLP Reports
11. US Drug Watchdog Now Urges Recipients Of The Recalled DePuy ASR Hip Implant To Call Them About A Just Announced Settlement If They Are Not Yet Represented By Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2020)... ... March 27, 2020 , ... The construction ... the spread of the coronavirus. Operating under the designation as an essential business ... renewal and environmental protection projects in the downstate New York region. , While ...
(Date:3/28/2020)... ... March 27, 2020 , ... Ahead of National ... edition of “The Fertility Journey.” This campaign will serve as a guide, showcasing ... maternal health options. , One in 6 couples experiences trouble with fertility. ...
(Date:3/28/2020)... ... 2020 , ... Confluent Health is proud to announce their ... since 1985 specializing in the treatment of orthopedic, sports, and work-related injuries with ... years ago, we have been committed to providing excellent quality of patient care ...
(Date:3/27/2020)... ... ... On March 27th, 2020, Talos Health Solutions , kicked off AsthmaCon ... caregivers living in the US. This free online conference will be available to the ... focus on asthma symptoms, the different kinds of asthma, treatment options, the experience of ...
(Date:3/27/2020)... ... 2020 , ... During a time of global distress and concern about the impact of COVID-19, ... UNITE HERE Education and Support Fund in an effort to assist hospitality workers whose ... represents 300,000 working people in the food service , hotel and other ...
Breaking Medicine News(10 mins):
(Date:4/1/2020)... ... 2020 , ... Dr. Michele S. Green, board-certified Anti-Aging Expert ... Beauty network. , The Haute Beauty Network, well known for its exclusivity, and ... , Haute Beauty offers a prominent collective of leading doctors nationwide. The invitation-only ...
(Date:3/30/2020)... Ala. (PRWEB) , ... March 30, 2020 , ... ... company, is launching a new solution, TalkWithYourDoc.com . By leveraging technology ... enables providers of all sizes to continue offering revenue-generating healthcare services while serving ...
(Date:3/30/2020)... ... 30, 2020 , ... “In the time of remote work ... stories from our customers of vendor price-gouging. We are here to promise that ... in this difficult time,” says Borya Shakhnovich, CEO of airSlate -- parent company ...
Breaking Medicine Technology: